Olopatadine Hydrochloride Ophthalmic Solution
NDC Package 24208-966-01
Package Information
Olopatadine Hydrochloride Ophthalmic Solution solution is adults and children 2 years of age and older:put 1 drop in the affected eye(s) twice daily, every 6 to 8 hours, no more than twice per dayif using other ophthalmic products while using this product, wait at least 5 minutes between each productreplace cap after each usechildren under 2 years of age:consult a doctor. This formulation utilizes a solution delivery system. Marketed by Bausch & Lomb Incorporated, this product is identified by NDC 24208-966 and is authorized under FDA application ANDA206046.
Identification & Billing
- RxCUI: 1111339 - olopatadine HCl 0.1 % Ophthalmic Solution
- RxCUI: 1111339 - olopatadine 1 MG/ML Ophthalmic Solution
- RxCUI: 1111339 - olopatadine 0.1 % Ophthalmic Solution
- RxCUI: 1111339 - olopatadine 1 MG/ML (as olopatadine HCl 1.11 MG/ML) Ophthalmic Solution
Clinical Specifications
- Decreased Histamine Release - [PE] (Physiologic Effect)
- Histamine H1 Receptor Antagonists - [MoA] (Mechanism of Action)
- Histamine-1 Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Histamine-1 Receptor Inhibitor - [EPC] (Established Pharmacologic Class)
- Mast Cell Stabilizer - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 24208 - Bausch & Lomb Incorporated
- 24208-966 - Olopatadine Hydrochloride Ophthalmic Solution
- 24208-966-01 - 1 BOTTLE in 1 CARTON / 5 mL in 1 BOTTLE
- 24208-966 - Olopatadine Hydrochloride Ophthalmic Solution
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (24208-966). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 24208-966-01 identifies a specific commercial package of 1 bottle in 1 carton / 5 ml in 1 bottle of Olopatadine Hydrochloride Ophthalmic Solution, a human over the counter drug labeled by Bausch & Lomb Incorporated. This solution is formulated for ophthalmic use and contains olopatadine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bausch & Lomb Incorporated on December 02, 2024. The current certification is valid through December 31, 2026.
How is this Bausch & Lomb Incorporated product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 24208096601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.